Dr. O. BROUCKAERT
ActiveSummary
Dr. O. BROUCKAERT has been active since 2018 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €71k and a net result of €432k. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 15% of 16546 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
74
/ 100
Healthy
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency37▲+6
Growth58=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €5k at 30 days acceptable
Liquidity short (current ratio 0.71 against 0.68 in 2024; short-term debt: 84.1% and cash: 28.2% of total assets), and 88.2% of the assets are financed with debt.
Credit check for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
11.8%
Return on assets
72.2%
Age of the figures
9 mo
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 15% of 16546 sector peers (2025).
NBB · sector comparisonPosition among 16546 sector peers
Solvency
better than 15%
← weakest
strongest →
lowers risk · Growing equity
Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.
NBB · annual accounts 2025Equity per financial year
1819202122232425
2018 to 2025 · latest year €71k
neutral · A punctual record breaks
This company filed 7 consecutive financial years on time. The year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-08-2026, 31 days late. Weigh it accordingly: a break into the 1-to-90-day band measures 1.41% abnormal legal state, below the 1.66% market average. It is a change in behaviour, not evidence of elevated risk.
NBB · 8 filingsDeviation from the deadline
2025
31 d late
2024
28 d early
2023
26 d early
2022
12 d early
2021
6 d early
2020
11 d early
2019
8 d early
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€71k▲ 84.0%
2024 · €38k
2018: €304k
2019: €596k
2020: €817k
2021: €60k
2022: €396k
2023: €19k
2024: €38k
2018 → 2025
Total assets
€599k▼ 13.5%
2024 · €693k
2018: €1.32M
2019: €1.70M
2020: €1.75M
2021: €763k
2022: €908k
2023: €779k
2024: €693k
2018 → 2025
Net result
€432k▲ 8.1%
2024 · €400k
2018: €292k
2019: €292k
2020: €220k
2021: €279k
2022: €337k
2023: €382k
2024: €400k
2018 → 2025
Working capital
€-148k▲ 6.8%
2024 · €-159k
2018: €-513k
2019: €622k
2020: €804k
2021: €10k
2022: €308k
2023: €-111k
2024: €-159k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€60k-€396k▲ 566%€19k▼ 95.3%€38k▲ 107%€71k▲ 84.0%
Operating result€370k-€447k▲ 20.6%€506k▲ 13.3%€530k▲ 4.7%€577k▲ 9.0%
Net result€279k-€337k▲ 20.6%€382k▲ 13.6%€400k▲ 4.6%€432k▲ 8.1%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result has risen four years in a row; 2025 is 9% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €599k
Fixed assets
€243k ▼ 30.2%
Current assets
€356k ▲ 3.4%
Equity and liabilities €599k
Equity
€71k ▲ 84.0%
Debt
€528k ▼ 19.3%
Debt's share of the balance-sheet total falls from 94.4% to 88.2%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€686k▲
2024 · €634k
Cash flow
€541k▲
2024 · €504k
Current ratio
0.71▲
2024 · 0.68
Debt to equity
7.46▼
2024 · 17.01
ROE
610.6%
ROA
72.2%▲
2024 · 57.7%
Interest coverage
155.83▲
2024 · 123.83
Debt ≤ 1 year
€504k▲
2024 · €503k
Debt > 1 year
€24k▼
2024 · €151k
Income taxes
€141k▲
2024 · €129k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 51 lines
Balance sheet
Code20242025
Assets
Total assets20/58€693k€599k▼
Fixed assets21/28€349k€243k▼
Intangible fixed assets21€278k€188k▼
Tangible fixed assets22/27€71k€56k▼
Plant, machinery and equipment23€1k€1k▼
Furniture and vehicles24€70k€55k▼
Current assets29/58€344k€356k▲
Amounts receivable within one year40/41€176k€181k▲
Trade receivables40€176k€181k▲
Other amounts receivable41€0-
Current investments50/53€0-
Cash at bank and in hand54/58€165k€169k▲
Deferred charges and accrued income490/1€4k€6k▲
Equity and liabilities
Total equity and liabilities10/49€693k€599k▼
Equity10/15€38k€71k▲
Contributions10/11€19k€19k=
Reserves13€20k€52k▲
Distributable reserves133€20k€52k▲
Profit (loss) carried forward14€0€0=
Amounts payable17/49€655k€528k▼
Amounts payable after more than one year17€151k€24k▼
Financial debts170/4€151k€24k▼
Amounts payable within one year42/48€503k€504k▲
Current portion of amounts payable after more than one year42€147k€127k▼
Financial debts43€22k€24k▲
Credit institutions430/8€22k€24k▲
Trade debts44€3k€3k▼
Suppliers440/4€3k€3k▼
Taxes, remuneration and social security45€8k€7k▼
Taxes450/3€5k€7k▲
Remuneration and social security454/9€3k€0▼
Other amounts payable47/48€322k€344k▲
Accrued charges and deferred income492/3€0-
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€104k€109k▲
Other operating charges640/8€63€0▼
Gross operating margin9900€634k€686k▲
Operating profit (loss)9901€530k€577k▲
Financial income75/76B€4k€0▼
Recurring financial income75€4k€0▼
Financial charges65/66B€5k€4k▼
Recurring financial charges65€5k€4k▼
Profit (loss) for the period before taxes9903€529k€573k▲
Income taxes67/77€129k€141k▲
Profit (loss) for the period9904€400k€432k▲
Profit (loss) for the period to be appropriated9905€400k€432k▲
Appropriation of the result
Profit (loss) to be appropriated9906€400k€432k▲
Transfer from equity791/2€0-
Transfer to equity691/2€20k€32k▲
To other reserves6921€20k€32k▲
Profit to be distributed694/7€380k€400k▲
Return on contributions (dividend)694€380k€400k▲
The notes to these accounts (12 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
31-08
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema · 31 days late
2025
31-12
Financial
Highest result since 2018net €432k ▲8.1%
Operating result €577k, net result €432k, both a record.
03-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
05-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
19-07
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
31-12
Financial
Liquidity triplescurrent ratio 3.16
Current ratio from 1.05 to 3.16; short-term debt falls from €205k to €142k.
31-12
Financial
Equity above €200kEq €396k ▲566%
5 profitable years in a row build equity to €396k.
25-07
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
20-07
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
31-12
Financial
Weakest financial yearnet €220k ▼24.6%
Net result drops to €220k, the lowest in the series; recovery starts the following year.
23-07
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
2019
31-12
Financial
Liquidity times 6current ratio 2.76
Current ratio from 0.50 to 2.76; short-term debt falls from €1.02M to €354k.
31-12
Financial
Equity above €500kEq €596k ▲96.1%
2 profitable years in a row build equity to €596k.
18-07
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
4 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Ieper · 1 establishment unit since 2018
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Zandvoordestraat 738902 IeperGround area
9,115 m²
Building footprint
239 m²
Volume, LiDAR
1,286 m³
Parcel 33036B0225/00K000, Flanders · tallest building 9.7 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Dr. O. BROUCKAERT
since 20182.273.224.494
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 33036B0225/00K000 | Flanders | 9,115 m² | 1 · 239 m² | 9.7 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
MD ANESTHESIE
BE 0760.537.903
Brussel · Eq €70,814
Dokter Pillen Sara
BE 1001.463.632
Merelbeke-Melle · Eq €70,815
Sara Lecoutere
BE 0682.633.441
Tongeren-Borgloon · Eq €70,900
MEDISCH CENTRUM GENK
BE 0431.775.110
Genk · Eq €70,679
Docteur Lilas Al Zein, Anesthésie Réanimation
BE 1009.077.637
Mont-Saint-Guibert · Eq €70,673
Of 16,627 companies in sector 86220 we hold annual accounts for 7,974. 5,728 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded20-02-2018
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
82990Other business support services
Sources
Crossroads Bank for EnterprisesNational Bank · 8 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.